NCT04480801

Brief Summary

The study was planned as a prospective randomized controlled clinical trial to determine the effect of thermal evaluation in preventing diabetic foot ulcers in patients with Type II Diabetes Mellitus (DM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 21, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 15, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

August 30, 2023

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

July 2, 2020

Last Update Submit

August 28, 2023

Conditions

Keywords

Diabetes Mellitusdiabetic footrisk factorsthermal evaluation

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients developing a foot ulcer

    There will be a correlation between diabetic foot development and high temperature values obtained from thermal evaluation.

    2 months after the first assessment

Secondary Outcomes (2)

  • Changes in blood sugar values

    2-month intervals until 1-year follow-up

  • Change in foot care practices

    2-month intervals until 1-year follow-up

Study Arms (2)

thermal evaluation and foot care

EXPERIMENTAL

Participants in the experimental group will be given foot care in the clinic and will be taught to the patient and / or their relatives. The foot care video will be uploaded to the patient and / or relative's phone. Thermal evaluation will be done. The application of the thermal evaluation, the foot areas to be applied and how to record the results of the application will be taught to the patient and / or their relatives. In addition, the thermal evaluation video will be uploaded to the phone of the patient and / or their relative. While the participants in the experimental group were discharged; Blood glucose monitoring chart, Checklist to record foot care interventions, Thermal evaluation registration form, Daily step number registration form will be provided and participants will be invited to check every 2 months.

Other: Thermal Evaluation and Foot Care

foot care

OTHER

Participants in the control group will be given foot care in the clinic and will be taught to the patient and / or their relatives. The foot care video will be uploaded to the patient and / or relative's phone.While the participants in the control group were discharged; Blood glucose monitoring chart, Checklist to record foot care interventions will be provided and participants will be invited to check every 2 months.

Other: Foot Care

Interventions

Participants in the experimental group will be given foot care and thermal evaluation in the clinic and will be taught to the patient and / or their relatives. Thermal evaluation and foot care video will be uploaded to the patient and / or relative's phone.

thermal evaluation and foot care

Participants in the control group will be given foot care in the clinic and will be taught to the patient and / or their relatives. Foot care video will be uploaded to the patient and / or relative's phone.

foot care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and over
  • Volunteer
  • Sign the informed consent form
  • Diagnosed with type II Diabetes Mellitus
  • No diabetic foot ulcer
  • Patients with no foot or toe amputation will be admitted.

You may not qualify if:

  • Does not sign the informed consent form
  • Without a smart phone
  • Diagnosed with Type I Diabetes Mellitus,
  • Patients with diabetic foot ulcers
  • With ankle / arm index \<0.9 and \>1.30,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necmettin Erbakan University

Konya, 42080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetic FootDiabetes Mellitus

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsEndocrine System DiseasesDiabetic NeuropathiesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • FATMA ÖZKAL

    Necmettin Erbakan University

    PRINCIPAL INVESTIGATOR
  • Serpil YÜKSEL, Phd

    Necmettin Erbakan University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: prospective randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 2, 2020

First Posted

July 21, 2020

Study Start

September 15, 2020

Primary Completion

June 15, 2022

Study Completion

June 1, 2023

Last Updated

August 30, 2023

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

Study Protocol

Shared Documents
STUDY PROTOCOL

Locations